Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $118.01 million. The enterprise value is $122.21 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, after market close.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.71 million shares outstanding. The number of shares has increased by 3.30% in one year.
| Current Share Class | 13.71M |
| Shares Outstanding | 13.71M |
| Shares Change (YoY) | +3.30% |
| Shares Change (QoQ) | +2.48% |
| Owned by Insiders (%) | 26.11% |
| Owned by Institutions (%) | 11.56% |
| Float | 5.11M |
Valuation Ratios
The trailing PE ratio is 18.82 and the forward PE ratio is 143.50.
| PE Ratio | 18.82 |
| Forward PE | 143.50 |
| PS Ratio | 2.02 |
| Forward PS | 2.05 |
| PB Ratio | 21.75 |
| P/TBV Ratio | 23.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 19.01 |
| EV / Sales | 2.09 |
| EV / EBITDA | 14.50 |
| EV / EBIT | 18.17 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 1.18.
| Current Ratio | 0.99 |
| Quick Ratio | 0.96 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | n/a |
| Interest Coverage | 240.14 |
Financial Efficiency
Return on equity (ROE) is 376.84% and return on invested capital (ROIC) is 47.78%.
| Return on Equity (ROE) | 376.84% |
| Return on Assets (ROA) | 14.64% |
| Return on Invested Capital (ROIC) | 47.78% |
| Return on Capital Employed (ROCE) | 62.51% |
| Revenue Per Employee | $279,005 |
| Profits Per Employee | $30,605 |
| Employee Count | 210 |
| Asset Turnover | 2.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.65% in the last 52 weeks. The beta is 0.20, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +72.65% |
| 50-Day Moving Average | 10.23 |
| 200-Day Moving Average | 6.46 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 44,180 |
Short Selling Information
The latest short interest is 123,944, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 123,944 |
| Short Previous Month | 115,685 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 2.43% |
| Short Ratio (days to cover) | 2.93 |
Income Statement
In the last 12 months, CSBR had revenue of $58.59 million and earned $6.43 million in profits. Earnings per share was $0.46.
| Revenue | 58.59M |
| Gross Profit | 30.22M |
| Operating Income | 6.72M |
| Pretax Income | -7.31M |
| Net Income | 6.43M |
| EBITDA | 8.43M |
| EBIT | 6.72M |
| Earnings Per Share (EPS) | $0.46 |
Full Income StatementBalance Sheet
The company has $3.20 million in cash and $6.44 million in debt, giving a net cash position of -$3.24 million or -$0.24 per share.
| Cash & Cash Equivalents | 3.20M |
| Total Debt | 6.44M |
| Net Cash | -3.24M |
| Net Cash Per Share | -$0.24 |
| Equity (Book Value) | 5.47M |
| Book Value Per Share | 0.40 |
| Working Capital | -173,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.30 million and capital expenditures -$133,000, giving a free cash flow of -$1.43 million.
| Operating Cash Flow | -1.30M |
| Capital Expenditures | -133,000 |
| Free Cash Flow | -1.43M |
| FCF Per Share | -$0.10 |
Full Cash Flow StatementMargins
Gross margin is 51.58%, with operating and profit margins of 11.48% and 10.97%.
| Gross Margin | 51.58% |
| Operating Margin | 11.48% |
| Pretax Margin | 10.92% |
| Profit Margin | 10.97% |
| EBITDA Margin | 14.38% |
| EBIT Margin | 11.48% |
| FCF Margin | n/a |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.30% |
| Shareholder Yield | -3.30% |
| Earnings Yield | 5.40% |
| FCF Yield | -1.20% |
Analyst Forecast
The average price target for CSBR is $12.00, which is 39.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 39.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 17.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
CSBR has an Altman Z-Score of 0.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 5 |